Company Filing History:
2 out of 274 
1 out of 205 
Years Active: 2005-2011
Title: Brian Ward: Innovator in Biomarker Research
Introduction
Brian Ward is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biomarker research, particularly in relation to infectious diseases. With a total of 2 patents, his work has the potential to impact diagnostics and treatment strategies.
Latest Patents
One of Brian Ward's latest patents is focused on serum biomarkers for Chagas disease. This invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying Chagas disease status in a patient. The biomarkers can effectively classify a subject sample as infected with Chagas disease or non-infected, and they can be detected by SELDI mass spectrometry. Another significant patent involves Toxoplasma gondii apical membrane antigen-1. This invention includes polypeptide fragments derived from TgAMA-1, nucleic acids that encode these fragments, and TgAMA-binding polypeptides such as antibodies. The methods outlined in this patent aim to produce vaccines and provide prevention and treatment strategies for Toxoplasmosis.
Career Highlights
Brian Ward has worked at prestigious institutions such as McGill University and the University of Vermont and State Agricultural College. His experience in these academic environments has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Gary E. Ward and Carolyn G. Conant. Their collaborative efforts have further advanced the research and development of innovative solutions in the field of biomarker discovery.
Conclusion
Brian Ward's contributions to biomarker research demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of infectious diseases and the potential for innovative diagnostic tools. His work continues to pave the way for future advancements in healthcare.